AFSTYLA is indicated in adult and paediatric patients with haemophilia A (congenital FVIII deficiency) for:
- Control and prevention of bleeding episodes
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- Perioperative management (surgical prophylaxis)
AFSTYLA is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White or slightly yellow lyophilised powder
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Solution
Clear solution
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, powder for
Blue polycarbonate transfer device (size 20/20)
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Not Scheduled.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AFSTYLA is indicated in adult and paediatric patients with haemophilia A (congenital FVIII deficiency) for:
- Control and prevention of bleeding episodes
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- Perioperative management (surgical prophylaxis)
AFSTYLA is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White or slightly yellow lyophilised powder
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Solution
Clear solution
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, powder for
Blue polycarbonate transfer device (size 20/20)
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Not Scheduled.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AFSTYLA is indicated in adult and paediatric patients with haemophilia A (congenital FVIII deficiency) for:
- Control and prevention of bleeding episodes
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- Perioperative management (surgical prophylaxis)
AFSTYLA is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White or slightly yellow lyophilised powder
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Solution
Clear solution
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, powder for
Blue polycarbonate transfer device (size 20/20)
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Not Scheduled.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AFSTYLA is indicated in adult and paediatric patients with haemophilia A (congenital FVIII deficiency) for:
- Control and prevention of bleeding episodes
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- Perioperative management (surgical prophylaxis)
AFSTYLA is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White or slightly yellow lyophilised powder
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Solution
Clear solution
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, powder for
Blue polycarbonate transfer device (size 20/20)
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Not Scheduled.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AFSTYLA is indicated in adult and paediatric patients with haemophilia A (congenital FVIII deficiency) for:
- Control and prevention of bleeding episodes
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- Perioperative management (surgical prophylaxis)
AFSTYLA is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White or slightly yellow lyophilised powder
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Solution
Clear solution
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, powder for
Blue polycarbonate transfer device (size 20/20)
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Not Scheduled.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AFSTYLA is indicated in adult and paediatric patients with haemophilia A (congenital FVIII deficiency) for:
- Control and prevention of bleeding episodes
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- Perioperative management (surgical prophylaxis)
AFSTYLA is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White or slightly yellow lyophilised powder
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Solution
Clear solution
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, powder for
Blue polycarbonate transfer device (size 20/20)
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Not Scheduled.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
Support for this browser is being discontinued
Support for this browser is being discontinued for this site
Internet Explorer 11 and lower
We currently support Microsoft Edge, Chrome, Firefox and Safari. For more information, please visit the links below: